Cargando…

Copeptin levels and blood lipid profile in borderline patients with or without self-mutilation

PURPOSE: Self-mutilation, known as self-harming behaviour of an individual without the intention of suicide, is commonly observed in individuals with borderline personality disorder. The objective of this study is to compare copeptin levels that are known to be related to aggressive behaviour and bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Korkmaz, Sevda, Üstündağ, Bilal, Özer, Ömer, Taşç, Gülay, Kaya, Şüheda, Ateşçelik, Metin, Atmaca, Murad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138163/
https://www.ncbi.nlm.nih.gov/pubmed/30263168
http://dx.doi.org/10.4102/sajpsychiatry.v22i1.976
_version_ 1783355300804296704
author Korkmaz, Sevda
Üstündağ, Bilal
Özer, Ömer
Taşç, Gülay
Kaya, Şüheda
Ateşçelik, Metin
Atmaca, Murad
author_facet Korkmaz, Sevda
Üstündağ, Bilal
Özer, Ömer
Taşç, Gülay
Kaya, Şüheda
Ateşçelik, Metin
Atmaca, Murad
author_sort Korkmaz, Sevda
collection PubMed
description PURPOSE: Self-mutilation, known as self-harming behaviour of an individual without the intention of suicide, is commonly observed in individuals with borderline personality disorder. The objective of this study is to compare copeptin levels that are known to be related to aggressive behaviour and blood lipid profiles in borderline patients with and without self-mutilation. METHODS: Twenty patients with self-mutilation [SM(+)] and 20 patients without self-mutilation [SM(−)] between the ages of 18 and 49, diagnosed with borderline personality disorder based on DSM-IV-TR(8) diagnostic criteria and attended to by Fırat University Psychiatry Polyclinic, participated in the study. Socio-demographic and clinical data form, Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale (HAMA) and Barrat Impulsivity Scale (BIS) were applied to all participants. Copeptin levels and plasma lipid levels were studied in the blood samples taken from the participants. RESULTS: Mean copeptin level found in SM(+) group (37.54 ± 18.8 ng/mL) was statistically significantly higher than SM(−) group (18.53 ± 16.6 ng/mL) (p = 0.002). A negative correlation was found between mean copeptin and mean total cholesterol levels (r = −0.436; p = 0.005), and between copeptin and low-density lipoprotein cholesterol (LDL) levels (r = −0.403; p = 0.01) in both SM(+) and SM(−) patient groups. HAMA mean score for SM(+) group was found as 36.45 ± 13.2, and for SM(−) group, it was found as 35.7 ± 12.9. There was a statistically significant difference between the depression points achieved by the two groups (p = 0.046). BIS total points average for SM(+) group was determined as 71 ± 9.71, whereas it was determined as 66.8 ± 7.92 in SM(−) group. There was no statistically significant difference between the groups based on anxiety points. Barrat planning, Barrat motor and Barrat attention points for SM(+) group were higher than the SM(−) group. However, the difference was not statistically significant (p > 0.05). CONCLUSION: Findings of the study demonstrated that as cholesterol and LDL levels decreased, copeptin levels increased, and that could be related to the self-mutilation behaviour.
format Online
Article
Text
id pubmed-6138163
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-61381632018-09-27 Copeptin levels and blood lipid profile in borderline patients with or without self-mutilation Korkmaz, Sevda Üstündağ, Bilal Özer, Ömer Taşç, Gülay Kaya, Şüheda Ateşçelik, Metin Atmaca, Murad S Afr J Psychiatr Original Research PURPOSE: Self-mutilation, known as self-harming behaviour of an individual without the intention of suicide, is commonly observed in individuals with borderline personality disorder. The objective of this study is to compare copeptin levels that are known to be related to aggressive behaviour and blood lipid profiles in borderline patients with and without self-mutilation. METHODS: Twenty patients with self-mutilation [SM(+)] and 20 patients without self-mutilation [SM(−)] between the ages of 18 and 49, diagnosed with borderline personality disorder based on DSM-IV-TR(8) diagnostic criteria and attended to by Fırat University Psychiatry Polyclinic, participated in the study. Socio-demographic and clinical data form, Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale (HAMA) and Barrat Impulsivity Scale (BIS) were applied to all participants. Copeptin levels and plasma lipid levels were studied in the blood samples taken from the participants. RESULTS: Mean copeptin level found in SM(+) group (37.54 ± 18.8 ng/mL) was statistically significantly higher than SM(−) group (18.53 ± 16.6 ng/mL) (p = 0.002). A negative correlation was found between mean copeptin and mean total cholesterol levels (r = −0.436; p = 0.005), and between copeptin and low-density lipoprotein cholesterol (LDL) levels (r = −0.403; p = 0.01) in both SM(+) and SM(−) patient groups. HAMA mean score for SM(+) group was found as 36.45 ± 13.2, and for SM(−) group, it was found as 35.7 ± 12.9. There was a statistically significant difference between the depression points achieved by the two groups (p = 0.046). BIS total points average for SM(+) group was determined as 71 ± 9.71, whereas it was determined as 66.8 ± 7.92 in SM(−) group. There was no statistically significant difference between the groups based on anxiety points. Barrat planning, Barrat motor and Barrat attention points for SM(+) group were higher than the SM(−) group. However, the difference was not statistically significant (p > 0.05). CONCLUSION: Findings of the study demonstrated that as cholesterol and LDL levels decreased, copeptin levels increased, and that could be related to the self-mutilation behaviour. AOSIS 2016-10-24 /pmc/articles/PMC6138163/ /pubmed/30263168 http://dx.doi.org/10.4102/sajpsychiatry.v22i1.976 Text en © 2016. The Authors http://creativecommons.org/licenses/by/2.0/ Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Original Research
Korkmaz, Sevda
Üstündağ, Bilal
Özer, Ömer
Taşç, Gülay
Kaya, Şüheda
Ateşçelik, Metin
Atmaca, Murad
Copeptin levels and blood lipid profile in borderline patients with or without self-mutilation
title Copeptin levels and blood lipid profile in borderline patients with or without self-mutilation
title_full Copeptin levels and blood lipid profile in borderline patients with or without self-mutilation
title_fullStr Copeptin levels and blood lipid profile in borderline patients with or without self-mutilation
title_full_unstemmed Copeptin levels and blood lipid profile in borderline patients with or without self-mutilation
title_short Copeptin levels and blood lipid profile in borderline patients with or without self-mutilation
title_sort copeptin levels and blood lipid profile in borderline patients with or without self-mutilation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138163/
https://www.ncbi.nlm.nih.gov/pubmed/30263168
http://dx.doi.org/10.4102/sajpsychiatry.v22i1.976
work_keys_str_mv AT korkmazsevda copeptinlevelsandbloodlipidprofileinborderlinepatientswithorwithoutselfmutilation
AT ustundagbilal copeptinlevelsandbloodlipidprofileinborderlinepatientswithorwithoutselfmutilation
AT ozeromer copeptinlevelsandbloodlipidprofileinborderlinepatientswithorwithoutselfmutilation
AT tascgulay copeptinlevelsandbloodlipidprofileinborderlinepatientswithorwithoutselfmutilation
AT kayasuheda copeptinlevelsandbloodlipidprofileinborderlinepatientswithorwithoutselfmutilation
AT atescelikmetin copeptinlevelsandbloodlipidprofileinborderlinepatientswithorwithoutselfmutilation
AT atmacamurad copeptinlevelsandbloodlipidprofileinborderlinepatientswithorwithoutselfmutilation